Showing results (21-30 of 162) with videos related to

Sort By:
Pageof 17
Experimental Hematology & Oncology|September 1, 2022
Metabolic cross-talk within the bone marrow milieu: focus on multiple myelomaInge Oudaert, Arne Van der Vreken, Anke Maes, et al.
Blood|April 9, 2004
Angiogenic switch during 5T2MM murine myeloma tumorigenesis: role of CD45 heterogeneityKewal Asosingh, Hendrik De Raeve, Eline Menu, et al.
Frontiers in Oncology|September 5, 2022
Aberrant DNA methylation in multiple myeloma: A major obstacle or an opportunity?Catharina Muylaert, Lien Ann Van Hemelrijck, Anke Maes, et al.
Scientific Reports|October 11, 2018
The genetic landscape of 5T models for multiple myelomaKen Maes, Bram Boeckx, Philip Vlummens, et al.
Oncotarget|March 8, 2016
Extracellular vesicle cross-talk in the bone marrow microenvironment: implications in multiple myelomaJinheng Wang, Sylvia Faict, Ken Maes, et al.
Clinical & Experimental Metastasis|December 25, 2002
Mechanisms involved in the differential bone marrow homing of CD45 subsets in 5T murine models of myelomaKewal Asosingh, Eline Menu, Els Van Valckenborgh, et al.
Cancer Research|July 18, 2008
A novel therapeutic combination using PD 0332991 and bortezomib: study in the 5T33MM myeloma modelEline Menu, Josefina Garcia, Xiangao Huang, et al.
Oncoimmunology|October 6, 2018
Epigenetic treatment of multiple myeloma mediates tumor intrinsic and extrinsic immunomodulatory effectsLien De Beck, Sarah Melhaoui, Kim De Veirman, et al.
British Journal of Haematology|January 18, 2006
The involvement of osteopontin and its receptors in multiple myeloma cell survival, migration and invasion in the murine 5T33MM modelJo Caers, Ursula Günthert, Hendrik De Raeve, et al.
Oncotarget|November 12, 2015
The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cellsJinheng Wang, Kim De Veirman, Nathan De Beule, et al.
Pageof 17